Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies - PubMed (original) (raw)
Case Reports
. 1993 Jan 2;341(8836):21-2.
doi: 10.1016/0140-6736(93)92485-c.
Affiliations
- PMID: 8093269
- DOI: 10.1016/0140-6736(93)92485-c
Free article
Case Reports
Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
R B Darnell et al. Lancet. 1993.
Free article
Abstract
We describe three patients with known or suspected small-cell lung cancer (SCLC), paraneoplastic neurological syndromes, and antineuronal antibodies who had unusually benign clinical courses. One patient survived 8 years free of disease and was positive for the anti-Hu antibody. A second patient survived 6 years after spontaneous tumour regression and had an atypical antineuronal antibody. A third patient with both the anti-Hu and atypical antineuronal antibody had spontaneous regression of a lung mass. All three patients had a subacute sensory neuropathy. Since paraneoplastic antineuronal antibodies also bind to tumour cells, these cases suggest that some (paraneoplastic) neurological syndromes without identifiable tumour may result from immune-mediated eradication of tumour cells.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical